Skip to main navigation Skip to search Skip to main content

Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C)

  • Alice Dewdney
  • , David Cunningham*
  • , Josep Tabernero
  • , Jaume Capdevila
  • , Bengt Glimelius
  • , Andres Cervantes
  • , Diana Tait
  • , Gina Brown
  • , Andrew Wotherspoon
  • , David Gonzalez De Castro
  • , Yu Jo Chua
  • , Rachel Wong
  • , Yolanda Barbachano
  • , Jacqueline Oates
  • , Ian Chau
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

371 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C)'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Medicine and Dentistry